FDA proposal to allow drug reps to circulate data draws protests

March 11, 2015 3:37 PM

5 0

(Reuters) - Consumer watchdog Public Citizen has called on U.S. health regulators to withdraw a proposal that would allow pharmaceutical companies to distribute medical literature suggesting that a drug's risk is less than stated on the label.

In a letter released on Wednesday, the organization urged Health and Human Services Secretary Sylvia Burwell to withdraw the proposal, saying pharmaceutical companies could "sell more drugs by making them seem safer than FDA has judged them to be."

Also read: Mike Pence: Trump's Taiwan Call Was Just 'Courtesy'

Read more

To category page

Loading...